This statistic shows the results of a survey conducted in the United States in February 2017, by gender. U.S. adults were given a list of 11 options and asked to select which consequences they would expect if U.S. pharma companies were forced to move their manufacturing from abroad back to the U.S. About 42 percent of female respondents said that they would expect higher drug prices, while 41 percent of male respondents indicated the same.
Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender
Original question: "A lot of US pharma companies manufacture abroad. Which consequences do you expect in case pharma companies were forced to manufacture in the US?" (multiple pick)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista Survey. (February 10, 2017). Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender [Graph]. In Statista. Retrieved November 23, 2024, from https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey. "Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender." Chart. February 10, 2017. Statista. Accessed November 23, 2024. https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey. (2017). Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender. Statista. Statista Inc.. Accessed: November 23, 2024. https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey. "Opinions on Consequences in Case U.S. Pharma Companies Would Be Forced to Manufacture In-country as of 2017, by Gender." Statista, Statista Inc., 10 Feb 2017, https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey, Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender Statista, https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/ (last visited November 23, 2024)
Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender [Graph], Statista Survey, February 10, 2017. [Online]. Available: https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
